Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Medicinal Chemistry|October 19, 2023
Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stabilityPrisca Lagardère, Romain Mustière, Nadia Amanzougaghene, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial PharmacophoreRomain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of Plasmodium falciparumDyhia Amrane, Christophe-Sébastien Arnold, Sébastien Hutter, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 22, 2026
n-Type Polymer Radio Frequency Rectifiers Operating at 18.5 GHzLazaros Panagiotidis, Filip Aniés, Yiyang Yu, et al.
European Journal of Medicinal Chemistry|March 21, 2015
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of PlasmodiumAnita Cohen, Peggy Suzanne, Jean-Charles Lancelot, et al.
European Journal of Medicinal Chemistry|August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesCyril Fersing, Clotilde Boudot, Julien Pedron, et al.
Fundamental & Clinical Pharmacology|January 12, 2011
Use of intravenous immunoglobulins in clinical practice: data from three French university hospitalsElisabeth Frauger, Jerome Grassi, Vincent Pradel, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Pageof 16